£110.00
Additional information
| Active substance | Mycophenolate Mofetil |
|---|---|
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Blood levels of mycophenolic acid may be monitored to adjust dose |
| Also known as | MMF |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Typically has no direct effect on blood pressure |
| Trade name | CellCept |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 2-Morpholinoethyl (E)-6-(1,3-dihydro-4-hydroxy-6-methoxy-7-methyl-3-oxo-5-isobenzofuranyl)-4-methyl-4-hexenoate |
| Formula | C23H31NO7 |
| Substance class | Immunosuppressant, specifically a prodrug of mycophenolic acid |
| Main action | Inhibits inosine monophosphate dehydrogenase, leading to suppression of lymphocyte proliferation |
| Half-life | Approximately 17.9 hours (for the active metabolite mycophenolic acid) |
| Dosage (medical) | Typically 1g orally twice a day |
| Dosage (sports) | Not applicable as it does not enhance athletic performance |
| Effects | Prevents organ rejection in transplant patients |
| Side effects | Gastrointestinal disturbances, increased risk of infections, leukopenia, anemia |
| Use in sports | Not typically used in sports due to its immunosuppressive effects |
| Manufacturer | Roche |
